chemicals-and-materials

United States Commercializing Biomarkers Market Report 2017


Published On : Aug 2017

Category : Chemicals

No. of Pages : 113 pages

  • $3800
  • $7600

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

United States Commercializing Biomarkers Market Report 2017
1 Commercializing Biomarkers Overview
1.1 Product Overview and Scope of Commercializing Biomarkers
1.2 Classification of Commercializing Biomarkers by Product Category
1.2.1 United States Commercializing Biomarkers Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Commercializing Biomarkers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Consumables
1.2.4 Services
1.2.5 Software
1.3 United States Commercializing Biomarkers Market by Application/End Users
1.3.1 United States Commercializing Biomarkers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 United States Commercializing Biomarkers Market by Region
1.4.1 United States Commercializing Biomarkers Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Commercializing Biomarkers Status and Prospect (2012-2022)
1.4.3 Southwest Commercializing Biomarkers Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Commercializing Biomarkers Status and Prospect (2012-2022)
1.4.5 New England Commercializing Biomarkers Status and Prospect (2012-2022)
1.4.6 The South Commercializing Biomarkers Status and Prospect (2012-2022)
1.4.7 The Midwest Commercializing Biomarkers Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Commercializing Biomarkers (2012-2022)
1.5.1 United States Commercializing Biomarkers Sales and Growth Rate (2012-2022)
1.5.2 United States Commercializing Biomarkers Revenue and Growth Rate (2012-2022)

2 United States Commercializing Biomarkers Market Competition by Players/Suppliers
2.1 United States Commercializing Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Commercializing Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Commercializing Biomarkers Average Price by Players/Suppliers (2012-2017)
2.4 United States Commercializing Biomarkers Market Competitive Situation and Trends
2.4.1 United States Commercializing Biomarkers Market Concentration Rate
2.4.2 United States Commercializing Biomarkers Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Commercializing Biomarkers Manufacturing Base Distribution, Sales Area, Product Type

3 United States Commercializing Biomarkers Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Commercializing Biomarkers Sales and Market Share by Region (2012-2017)
3.2 United States Commercializing Biomarkers Revenue and Market Share by Region (2012-2017)
3.3 United States Commercializing Biomarkers Price by Region (2012-2017)

4 United States Commercializing Biomarkers Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Commercializing Biomarkers Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Commercializing Biomarkers Revenue and Market Share by Type (2012-2017)
4.3 United States Commercializing Biomarkers Price by Type (2012-2017)
4.4 United States Commercializing Biomarkers Sales Growth Rate by Type (2012-2017)

5 United States Commercializing Biomarkers Sales (Volume) by Application (2012-2017)
5.1 United States Commercializing Biomarkers Sales and Market Share by Application (2012-2017)
5.2 United States Commercializing Biomarkers Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Commercializing Biomarkers Players/Suppliers Profiles and Sales Data
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Commercializing Biomarkers Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Commercializing Biomarkers Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.2 Commercializing Biomarkers Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 BD
6.4.2 Commercializing Biomarkers Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 BD Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Abbott
6.5.2 Commercializing Biomarkers Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Abbott Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Genesys Biolabs(20/20GeneSystems)
6.6.2 Commercializing Biomarkers Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Genesys Biolabs(20/20GeneSystems) Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Affymetrix
6.7.2 Commercializing Biomarkers Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Affymetrix Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Agendia
6.8.2 Commercializing Biomarkers Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Agendia Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 ALMAC
6.9.2 Commercializing Biomarkers Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 ALMAC Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Arrayit
6.10.2 Commercializing Biomarkers Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Arrayit Commercializing Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Biocartic
6.12 BG Medicine
6.13 KEGG EXPRESSION Database
6.14 Thermo Fisher
6.15 BGI

7 Commercializing Biomarkers Manufacturing Cost Analysis
7.1 Commercializing Biomarkers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Commercializing Biomarkers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Commercializing Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Commercializing Biomarkers Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Commercializing Biomarkers Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Commercializing Biomarkers Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Commercializing Biomarkers Sales Volume Forecast by Type (2017-2022)
11.3 United States Commercializing Biomarkers Sales Volume Forecast by Application (2017-2022)
11.4 United States Commercializing Biomarkers Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Back To Top